Yiqing Song, M.D., Sc.D.
714 North Senate Ave.
Indianapolis, IN 46202
Phone: (317) 274-3833
Fax: (317) 274-3443
Research Program Membership
Department of Epidemiology
IU School of Public Health
I have extensive experience in the evaluation of nutritional, biochemical and genetic markers of risk of obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease in the Women's Health Study (WHS). I have authored and co-authored several publications on nutritional, biochemical (including lipid profiles) and genetic markers in relation to colorectal adenoma, breast cancer, and melanoma. I also have extensive expertise and experience in the ascertainment of cancer endpoints in large cohorts. I have been the PI and Co-PI on a number of NIH-funded grants. Currently, I am the PI of a NHLBI-supported R01 grant to conduct a comprehensive evaluation of the full spectrum of variation in biomarkers of vitamin D/parathyroid hormone (PTH) endocrine system and to examine their potential contributions to racial/ethnic disparities in CVD risk in the WHI-OS. I also serve as the PI of a diabetes prevention trial to test whether vitamin D and omega-3 supplementation will reduce the risk of type 2 diabetes in the VITamin D and OmegA-3 TriaL (VITAL), a trial that evaluates the balance of benefits and risks of vitamin D3 (2,000 IU/day) and marine omega-3 fatty acid (eicosapentaenoic acid [EPA] + docosahexaenoic acid [DHA], 840mg/day) supplements in primary prevention of cardiovascular disease and cancer among 20,000 U.S. men and women. I also leads another VITAL ancillary study to test the hypothesis that magnesium status interacts with vitamin D treatment to affect type 2 diabetes and CVD risk as well as longitudinal change in intermediate cardiometabolic phenotypes. In addition, I have been involving in a comprehensive, prospective cohort evaluation of standard lipid markers of total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides, and novel lipid markers of apolipoproteins A-1 and B100, as well as long-term use of statins in relation to risk of total invasive cancer and breast, colorectal and endometrial cancer in the Women's Health Study. I used to be the PI of this research and continue to serve as the Co-investigator assisting the PI for the study conduct, data collection and statistical analysis, interpretation, manuscript preparation, and dissemination of findings. I have a long-standing interest in the fields of cancer prevention research related to nutrition, dyslipidemia, obesity, and diabetes.
Sc.D. - Harvard School of Public Health, Boston, MA 2005
M.A. - University of Texas at Austin, Austin, TX 2000
M.D. - Beijing Medical University, Beijing, China 1993